C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2006
12/27/2006	CN1291979C Imidazole compounds and their use as adenosine deaminase inhibitors
12/26/2006	US7153977 Ligands and methods for preparing same
12/26/2006	US7153959 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis
12/26/2006	US7153889 Alzheimer's disease; antihistamines; attention deficit disorders; hyperactivity; bipolar disorders; cognition activators; psychological disorders; anticancer agents; antidepressants; antiepileptic agents; gastrointestinal disorders ; analgesics
12/26/2006	US7153883 Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
12/26/2006	US7153881 Compounds acting as melanocortin receptor ligands
12/26/2006	US7153872 Cancer and fibrotic diseases
12/26/2006	US7153871 Antiinflammatory agents; cognition activators; asthma therapy; antiarthritic agents; side effect reduction
12/26/2006	US7153862 αv integrin receptor antagonists
12/26/2006	US7153852 Skin disorders; antiinflammatory agents; brain disorders; chronic obstructive pulmonary disease; antiarthritic agents; inflammatory bowel disorders
12/21/2006	WO2006135826A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/21/2006	WO2006135721A1 Alkylquinoline and alkylquinazoline kinase modulators
12/21/2006	WO2006135646A1 Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators and related methods of synthesis
12/21/2006	WO2006134989A1 Nitrogenated heterocyclic compound
12/21/2006	WO2006134460A1 Chromane substituted benzimidazole derivatives as acid pump antagonists
12/21/2006	WO2006134318A1 Pyrazole-substituted benzimidazole derivatives for use in the treatment of cancer and autoimmune disorders
12/21/2006	WO2006134163A2 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
12/21/2006	WO2006134150A1 Benzofuranyl derivatives as 5-ht6-receptor inhibitors
12/21/2006	WO2006133821A1 Tetrahydroquinolines used in the form of modulators of mitotic motor-proteins eg5
12/21/2006	WO2006092599A3 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
12/21/2006	WO2006083673A3 Pyridine derivatives useful as inhibitors of c-jun n-terminal kinases
12/21/2006	WO2006064217A3 PROCESS FOR THE PREPARATION OF 4-(6-CHLORO-2, 3-METHYLENEDIOXYANILINO)-7-[2-(4-METHYLPIPERAZIN-l-YL) ETHOXY]-5-TETRAHYDROPYRAN-4-YLOXYQUINAZOLINE , THEIR INTERMEDIATES AND CRYSTALLINE SALTS THEREOF
12/21/2006	WO2005110994A8 Substituted pyrazolyl urea derivatives useful in the treatment of cancer
12/21/2006	WO2005047244A3 Inhibition of fgfr3 and treatment of multiple myeloma
12/21/2006	US20060287387 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
12/21/2006	US20060287379 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
12/21/2006	US20060287378 Novel pyrroles and imidazoles
12/21/2006	US20060287377 Vanilloid receptor 1 (VR 1) antagonists; efficacy; N-(3-Fluoro-4-methoxy-phenyl)-2-(7-nitro-1H-benzimidazol-1-yl)-acetamide,
12/21/2006	US20060287370 Isoindolinone kinase inhibitors
12/21/2006	US20060287369 Diarylmethyl and related compounds
12/21/2006	US20060287363 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht 1f agonists
12/21/2006	US20060287361 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof as opoid receptors ligands
12/21/2006	US20060287340 e.g. 5-(4-fluorophenyl)-N-[2-(1-methyl-2-oxo-1,7-diazaspiro[4,4]nonan-7-yl)-6-quinolinyl]-2-pyrimidinecarboxamide; melanin concentrating hormone receptor antagonist; central nervous system disorders, cardiovascular disorders and metabolic disorders
12/21/2006	US20060287295 Antiproliferative agent in the prevention or treatment of tumors which are sensitive to inhibition of EGF and erbB receptor tyrosine kinases;1-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}methyl)-L-prolinamide
12/21/2006	US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction
12/21/2006	US20060287291 such as 2-Methoxy-5-methyl-N-[7-(piperazin-1-ylcarbonyl)-1-benzofuran-5-yl]benzenesulfonamide for treating disorders related to 5-HT6 receptor related disorders such as obesity, type II diabetes, anxiety, depression, panic attacks, memory/sleep/cognitive disorders, epilepsy, obsessive compulsive disorder
12/21/2006	DE102005018026B4 Substituierte Styrole, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Substituted styrenes, processes for their preparation and their use as anti-inflammatories
12/21/2006	CA2611893A1 Tetrahydroquinolines for use as modulators of the mitotic motor protein eg5
12/21/2006	CA2611711A1 Piperazine-piperidine antagonists and agonists of the 5-ht1a receptor
12/21/2006	CA2611443A1 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
12/21/2006	CA2611242A1 Alkylquinoline and alkylquinazoline kinase modulators
12/21/2006	CA2611219A1 Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators and related methods of synthesis
12/21/2006	CA2610588A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/21/2006	CA2610383A1 Benzofuranyl derivatives as 5-ht6-receptor inhibitors
12/21/2006	CA2608582A1 Chromane substituted benzimidazole derivatives as acid pump antagonists
12/20/2006	EP1734041A2 Platelet ADP receptor inhibitors
12/20/2006	EP1734040A1 Substituted quinazoline or pyridopyrimidine derivative
12/20/2006	EP1734034A2 Carboxylic acid salts of beta-alanine esters or -amides
12/20/2006	EP1733726A1 Pharmaceutically active isoindoline derivatives
12/20/2006	EP1732901A1 Antiviral 4-aminocarbonylamino-substituted imidazole compound
12/20/2006	EP1732900A2 Acrylonitrile derivatives for inflammation and immune-related uses
12/20/2006	EP1732896A1 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
12/20/2006	EP1732884A1 Sulphonamide derivatives
12/20/2006	EP1732564A1 Biaryl substituted pyrazinones as sodium channel blockers
12/20/2006	EP1732385A1 Use of (3-(1-(3-phenyl-propenyl)-piperidin-4-yl)-2,3-dihydro-indol-1-yl)-(pyridin-4-yl)-methanone derivatives and related compounds as insecticides
12/20/2006	EP1651220B1 2-[4- (2-hydroxymethyl-phenylamino)-piperidin-1-yl] - n-(9h-carbazol-3-yl) - acetamide derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity
12/20/2006	EP1648458B1 2-[4(phenylamino)-piperidin-1-yl]-n-phenyl-acetamide derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity
12/20/2006	EP1622610B1 1-(2h-pyrazol-3-yl)-3-{4-[1-(benzoyl)-piperidin-4-ylmethyl]-phenyl}-urea derivatives and related compounds as inhibitors of p38 kinase and/or tnf inhibitors for the treatment of inflammations
12/20/2006	EP1542977B1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12.
12/20/2006	EP1390362B1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
12/20/2006	EP1305308B1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
12/20/2006	EP1263729B1 Azacyclic compounds for use in the treatment of serotonin related diseases
12/20/2006	EP0794946B1 Alkylidenehydrazinophenylsulphonyl ureas, methods of preparing them and their use as herbicides and plant-growth regulators
12/20/2006	CN1882580A Quinazoline derivatives as antiproliferative agents
12/20/2006	CN1882579A Substituted heteroaryl benzofuran acids
12/20/2006	CN1882578A 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors
12/20/2006	CN1882567A Quinazoline derivatives as tyrosine kinase inhibitors
12/20/2006	CN1882547A 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
12/20/2006	CN1882545A Substituted nicotinoylcarbamates as pesticides
12/20/2006	CN1882542A 2-pyridone derivatives as neutrophil elastase inhibitors and their use
12/20/2006	CN1882332A Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
12/20/2006	CN1880304A Triamide-substituted indoles, benzofuranes and benzothiophenes
12/20/2006	CN1879619A Cancer treatment
12/20/2006	CN1290855C Nucleotide analogs with six-membered rings
12/20/2006	CN1290501C Pharmaceutically active isoindoline derivatives
12/19/2006	US7151183 Processes for preparing amorphous atorvastatin hemi-calcium
12/19/2006	US7151179 7-ethyl-20(S)-camptothecin; reduction and subsequent oxidation of chemical intermediates to form Irinotecan; catalysis
12/19/2006	US7151118 N-(6-Methyl-4'-{[3-(4-methylpiperazin-1-yl)propylamino]carbonyl}-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis
12/19/2006	US7151113 Pyrazole-amine compounds useful as kinase inhibitors
12/19/2006	US7151110 4-Methoxy-6-[3-(6-methyl-pyridin-2-yl)-1H-pyrazol-4-yl]-quinoline; inhibits the TGF-beta signaling pathway; anticancer, antifibrotic, antitumor, and antiproliferative agents
12/19/2006	US7151102 Phthalazinone derivatives
12/19/2006	US7151098 Glutamate receptor antagonists
12/19/2006	CA2297439C Carbostyril derivatives
12/19/2006	CA2158863C Taxanes having a pyridyl substituted side-chain
12/14/2006	WO2006132442A1 Vitamin d-like compound
12/14/2006	WO2006132192A1 Novel 2-quinolone derivative
12/14/2006	WO2006131519A1 Quinoline derivatives as antibacterial agents
12/14/2006	WO2006131304A2 Process for preparing renin inhibitors
12/14/2006	WO2006131303A2 Peptide deformylase (pdf) inhibitors 4
12/14/2006	WO2006073589A3 Cycloalkyl keto piperidine tachykinin receptor antagonists
12/14/2006	US20060281920 such as 6-(4-ethoxy-phenyl)-2S-hydroxy-3R-[4-(3-methoxy-phenyl)-piperazine-1-carbonyl]-hexanoic acid hydroxyamide, used for the treatment or prophylaxis of arthritis in mammals
12/14/2006	US20060281800 Polymorphic form of olmesartan and process for its preparation
12/14/2006	US20060281784 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
12/14/2006	US20060281774 Pyrimidine derivatives for the treatment of abnormal cell growth
12/14/2006	US20060281753 4-(Aminomethyl)-piperidine benzamides as 5ht4 - antagonists
12/14/2006	US20060281734 3-[5-(3-acetamidobenzamido)-2-methylphenyl]-6-(4-methylpiperazin-1-yl)-3,4-dihydroquinazolin-4-one for example; treating rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease; inhibitor of cytokine-mediated disease
12/14/2006	US20060281694 Procyanidins as antineoplastic agents; topolisomerase, cylooxygenase, and/or lipoxygenase inhibitors; nitric oxide synthase modulators; hypotensive agents; treatment of gingivitis; platelet aggregation modulation
12/14/2006	DE102005026231A1 Peptid-Deformylase (PDF) Inhibitoren 3 Peptide deformylase (PDF) inhibitors 3
12/14/2006	CA2610304A1 Peptide deformylase (pdf) inhibitors 4
12/14/2006	CA2608575A1 Process for preparing renin inhibitors

1 ... 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 ... 694